title: Etiology of acute myeloid leukemia following intensive therapy for AML--relapse, secondary disease or bad luck?
authors.forename: J
authors.initials: J
authors.lastname: Braess
authors.forename: C
authors.initials: C
authors.lastname: Schoch
authors.forename: M
authors.initials: M
authors.lastname: Fiegl
authors.forename: C
authors.initials: C
authors.lastname: Schmid
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
authors.forename: H-J
authors.initials: HJ
authors.lastname: Kolb
mesh_terms: D000208:Acute Disease; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D020732:Cytogenetic Analysis; D005260:Female; D006410:Hematopoiesis / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007951:Leukemia, Myeloid / Q000139:chemically induced* / Q000209:etiology / Q000473:pathology; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000209:etiology / Q000235:genetics; D012008:Recurrence; D014184:Transplantation, Homologous